Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIn the UK, Wegovy 1.7mg is a prescription-only dose within the weekly semaglutide titration schedule, and private pricing for it varies between providers — typically sitting within the broader range of roughly £149–£375 per month reported across the market since Novo Nordisk adjusted its pricing in 2025. The honest answer upfront: you can't buy any dose of Wegovy as a consumer product, and the number that matters is never the headline figure alone. These are prescription medicines, and a GPhC-registered prescriber must assess whether Wegovy is clinically appropriate for you before any treatment begins. If you've been comparing prices for the 1.7mg dose specifically and wondering what you're actually paying for, read on.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people searching for a Wegovy 1.7mg price comparison arrive expecting something like a consumer goods market, a list of retailers, a clear winner on cost. That's not how this works, and the reason matters.
Wegovy is a Prescription-Only Medicine. The 1.7mg dose isn't a standalone product you select from a menu; it's one step in a titration schedule that a prescriber manages. How Wegovy works as a treatment is shaped by that schedule: doses increase gradually from 0.25mg, and reaching 1.7mg means a prescriber has already assessed your progress, tolerance and clinical picture at least three times. No legitimate pharmacy issues a 1.7mg pen without that ongoing oversight. So when a comparison site lists a price for this dose, what it's showing you (at best) is the cost of one pen within a managed programme. At worst, it's a listing with no prescriber attached at all.
NICE's appraisal of semaglutide for weight management (NICE TA875) recommends its use within a specialist weight management service with multidisciplinary support. That framework exists because the clinical oversight isn't a box-ticking exercise, it's where the safety and the results actually come from. A price comparison that ignores what surrounds the pen is comparing the wrong thing.
Worth knowing: the 1.7mg dose is the penultimate step before the standard 2.4mg maintenance dose. If you're at this stage, your prescriber is the right person to talk to about timing and what comes next, and understanding how the 1mg dose sits within the broader pricing picture can also help you make sense of how costs shift as your titration progresses.
Private Wegovy pricing in the UK is genuinely variable, and the figure that appears on a provider's homepage often covers less than patients expect. The things most commonly omitted from headline prices include: an initial consultation fee charged separately; a prescription fee on top of the medicine cost; delivery charges (which can be £5–£15 per order); and any form of clinical follow-up between doses.
Some providers charge for dose-increase reviews. Others require a separate subscription to access aftercare. A few bundle the medicine with an app and call it a programme, but the prescriber contact, if it exists at all, is asynchronous and slow. If you're partway through your titration and need clinical input quickly, that matters.
The full picture of Wegovy pricing in the UK shows why comparing a single number across providers without reading the small print rarely ends up being the saving it first appears. Add up the real costs: consultation, prescription, delivery, and aftercare access across several months, and the gap between a cheap headline and a complete service often closes considerably.
For reference, Novo Nordisk's UK list pricing informs private market rates, and if you want a structured overview across every dose tier, the Wegovy price comparison list for the UK is a useful place to see how those figures stack up by dose and provider. Those figures are the only market-level numbers worth using as a benchmark, per-pen prices from any individual provider should be checked directly on their treatment pages, not in body copy on comparison sites.
At nume, one price covers the consultation, the prescription, the treatment, next-working-day tracked delivery through DPD, and ongoing clinical access seven days a week. Nothing is added at the basket. No subscription, no auto-renewal, every repeat order goes through a fresh prescriber review before it's approved. Your pen travels in plain packaging and tends to arrive before lunch if you ordered by 12pm the previous working day.
We're not the cheapest option. That's a deliberate position, not an oversight. A GPhC-registered online pharmacy with its own dispensary (you can verify ours on the GPhC register, premises number 9012878) costs more to run than a referral platform with a third-party dispensary. Those costs fund the photo-ID verification, live weight checks on video, GP notification, and the prescriber who reviews your case personally. If you'd like to understand the clinical team behind that process, our prescriber profile gives you the detail.
You can explore our treatment options and current pricing on the treatment page, that's the right place to see exactly what's included and at what cost, rather than a generalised comparison article. And if the 1.7mg dose is where you are in your titration, reviewing how the 2.4mg maintenance dose is priced across UK providers is worth doing alongside this, so you can plan ahead with a realistic sense of what the next step involves.
The MHRA has warned publicly about counterfeit semaglutide pens sold online, in 2025, enforcement operations seized around 20 million doses of illegally traded weight-loss medicines worth approximately £45 million, and a UK site producing counterfeit tirzepatide pens was raided. Fake pens have been found to contain insulin, with serious consequences for the people who used them. The pattern is consistent: prices well below the market, sellers operating through social media, no verifiable pharmacy registration, and sometimes discount codes used to create urgency. You can report suspected counterfeit sellers at the MHRA's Yellow Card service.
For a Prescription-Only Medicine, the question of who reviewed your health, who dispensed the pen, and who you can call if something feels wrong is the one that actually protects you. A small monthly saving does not answer that question. Weight loss treatment that's clinically supervised and dispensed from a verified UK pharmacy isn't a premium you're paying for convenience, it's the minimum standard a prescription medicine requires. Speak to our prescribers if you'd like to understand your options properly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.